Fingerprint
Dive into the research topics of 'Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
Philippe Bégin, Tina Dominguez, Shruti P. Wilson, Liane Bacal, Anjuli Mehrotra, Bethany Kausch, Anthony Trela, Morvarid Tavassoli, Elisabeth Hoyte, Gerri O'Riordan, Alanna Blakemore, Scott Seki, Robert G. Hamilton, Kari C. Nadeau
Research output: Contribution to journal › Article › peer-review
138
Scopus
citations